Case Report
Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma
Table 1
Laboratory values before, during, and after therapy.
| | FVIII:C (IU/ml) | VWF:Ag (IU/ml) | VWF:RCo (IU/ml) |
| Normal values | 0.60–1.50 | 0.50–2.10 | 0.40–2.10 | Prechemotherapy | 0.34 | 0.32 | 0.31 | After R-CHOP cycle 1 | 0.60 | 0.51 | n/a | After R-CHOP cycle 2 | 2.18 | 1.47 | >1.00 | After R-CHOP cycle 3 | 2.12 | 1.70 | >1.00 | After cytarabine + rituximab (cycles 1 and 2) | 2.18 | 1.94 | n/a | Follow-up | 2.32 | 2.03 | >1.00 |
|
|
n/a: not available.
|